| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
99mTc-demotide
2
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: radiopharmaceutical; structure in first source
Also Known As:(99mTc)demotide; 99m Tc demotide
Bio-Agent Context: Research Results
Related Diseases
| 1. | Neoplasms (Cancer)
02/01/2006
- "However, both [(99m)Tc]Demotide and [(99m)Tc]Demotate 4 showed unfavorably higher background activity, especially in the abdomen, in comparison to [(99m)Tc]Demotate 1 and are, therefore, less suited than [(99m)Tc]Demotate 1 for sst(2)-targeted tumor imaging in man."
01/01/2006 - "CONCLUSION: The above favorable characteristics validate [99mTc]Demotide as a promising 99mTc-radiotracer for the targeted-imaging of sst2-positive tumors." 01/01/2006 - "The in vitro properties of Demotide and [99mTc]Demotide were tested in sst2-expressing CA20948 cells and rat tissues, while biodistribution was studied in Lewis rats bearing CA20948 tumors" Get all the results and reference details, order at left... |
| 1 Diseases and 2 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |